182 related articles for article (PubMed ID: 19244162)
1. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.
Heeb MJ; Prashun D; Griffin JH; Bouma BN
FASEB J; 2009 Jul; 23(7):2244-53. PubMed ID: 19244162
[TBL] [Abstract][Full Text] [Related]
2. Zn²(+) -containing protein S inhibits extrinsic factor X-activating complex independently of tissue factor pathway inhibitor.
Fernandes N; Mosnier LO; Tonnu L; Heeb MJ
J Thromb Haemost; 2010 Sep; 8(9):1976-85. PubMed ID: 20492471
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
[TBL] [Abstract][Full Text] [Related]
4. Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.
Stavenuiter F; Davis NF; Duan E; Gale AJ; Heeb MJ
Thromb Haemost; 2013 Feb; 109(2):229-37. PubMed ID: 23238804
[TBL] [Abstract][Full Text] [Related]
5. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
[TBL] [Abstract][Full Text] [Related]
6. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.
Heeb MJ; Koenen RR; Fernández JA; Hackeng TM
J Thromb Haemost; 2004 Oct; 2(10):1766-73. PubMed ID: 15456488
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
8. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
[TBL] [Abstract][Full Text] [Related]
9. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
10. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
11. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
12. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
[TBL] [Abstract][Full Text] [Related]
13. Protein S multimers and monomers each have direct anticoagulant activity.
Heeb MJ; Schuck P; Xu X
J Thromb Haemost; 2006 Feb; 4(2):385-91. PubMed ID: 16420570
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
15. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
[TBL] [Abstract][Full Text] [Related]
16. Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.
Borgel D; Gaussem P; Garbay C; Bachelot-Loza C; Kaabache T; Liu WQ; Brohard-Bohn B; Le Bonniec B; Aiach M; Gandrille S
Biochem J; 2001 Dec; 360(Pt 2):499-506. PubMed ID: 11716779
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
Koshiar RL; Somajo S; Norström E; Dahlbäck B
PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
[TBL] [Abstract][Full Text] [Related]
18. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
[TBL] [Abstract][Full Text] [Related]
19. Protein S binds to and inhibits factor Xa.
Heeb MJ; Rosing J; Bakker HM; Fernandez JA; Tans G; Griffin JH
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2728-32. PubMed ID: 8146182
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]